TCT 662: Long-term Clinical Outcomes from 2 European Centres Following the Use of Sirolimus-Coated Balloon in Small Vessel and Long-Lesions in De-novo Segments

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Concept Medical; Shockwave Medical